News coverage about Neptune Technologies & Bioresources (NASDAQ:NEPT) (TSE:NTB) has been trending somewhat positive recently, according to Accern Sentiment. Accern identifies positive and negative press coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Neptune Technologies & Bioresources earned a daily sentiment score of 0.07 on Accern’s scale. Accern also gave news stories about the biotechnology company an impact score of 45.3740094581322 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

Neptune Technologies & Bioresources (NEPT) traded down 1.17% during mid-day trading on Wednesday, reaching $0.85. The company’s stock had a trading volume of 179,523 shares. The firm has a market capitalization of $66.84 million, a price-to-earnings ratio of 13.08 and a beta of 0.83. Neptune Technologies & Bioresources has a 1-year low of $0.70 and a 1-year high of $1.53. The firm has a 50-day moving average of $0.86 and a 200 day moving average of $0.95.

TRADEMARK VIOLATION WARNING: “Neptune Technologies & Bioresources (NEPT) Getting Somewhat Favorable Press Coverage, Analysis Shows” was first reported by Daily Political and is the property of of Daily Political. If you are viewing this report on another publication, it was illegally copied and republished in violation of US and international copyright & trademark law. The correct version of this report can be accessed at https://www.dailypolitical.com/2017/09/13/neptune-technologies-bioresources-nept-getting-somewhat-favorable-press-coverage-analysis-shows.html.

About Neptune Technologies & Bioresources

Neptune Technologies & Bioressources Inc is a solution provider of omega-3’s and other functional ingredients to branded marketers in the nutraceutical industry, primarily in North America. The Company is engaged in the development, manufacture and commercialization of marine-derived omega-3 fatty acids.

Insider Buying and Selling by Quarter for Neptune Technologies & Bioresources (NASDAQ:NEPT)

Receive News & Ratings for Neptune Technologies & Bioresources Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neptune Technologies & Bioresources Inc and related companies with MarketBeat.com's FREE daily email newsletter.